Should a QP audit CROs and Investigators?
Recommendation
18-20 November 2026
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
As third set in row of Q&A documents, the European QP Association has published a Q&A document on IMP-related questions.
The new set of questions (on the European QP Association website) is dealing with topics like:
- Completeness of the IMPD
- Reanalysis of IMPs
- Audits
- Contracts
Related GMP News
27.10.2026ICH publishes Online Training Materials for ICH E6(R3) Good Clinical Practice
07.10.2026FDA: Next Step to Reduce Animal Based Testing Methods
23.09.2026FDA Publishes Draft Guidance on Potency Testing of Active Immunotherapy Products
27.08.2026EMA publishes Consolidated ICH E6(R3) Guideline
28.07.2026WHO publishes GCP Guidelines for Comment
09.07.2026Final ICH E6(R3) Annex 2